Thioctic acid

Specifications

214-071-2EC Number

5-(dithiolan-3-yl)pentanoic acidIUPAC Name

C8H14O2S2Chemical Formula

206.3 g/molMolecular Weight

thioctic acid; alpha-Lipoic acid; 6,8-Thioctic acid; Biletan; alpha Lipoic Acid; DL-6,8-Thioctic acid; 5-(dithiolan-3-yl)pentanoic acid; Thioctsan; thioctate; Thiocacid; Thioctan; Tioctic Acid; Acidum thiocticum; A-lipoicum acidum; Lipoic acid, dl-; Lipoic acid, alpha; biomolipon; AlphaLipogamma; biomo lipon; espa lipon; Alpha Lipogamma; Pleomix Alpha; Verla Lipon; AlphaLipon Stada; Alpha Lippon AL; Alpha Lipon Stada; Liponsaureratiopharm; NSC-90788; CHEBI:16494; 73Y7P0K73Y; alpha Liponsaure von ct; NSC-628502; espalipon; alphaVibolex; PleomixAlpha; VerlaLipon; alpha Vibolex; Thiogamma oral; PleomixAlpha N; AlphaLippon AL; Pleomix Alpha N; MTWAlphaliponsaure; Injekt, Thiogamma; Thioctic acid dl-; MTW Alphaliponsaure; Acid, alpha-Lipoic; Liponsaure ratiopharm; alphaLiponaure Heumann; alphaLiponsaure von ct; AlphaLiponsaure Sofotec; alpha Liponaure Heumann; Alpha Liponsaure Sofotec; Alpha Lipoic Acid 1 mg; RefChem:389317; PureVita Alpha Lipoic Acid; dl-Thioctic acid; 1077-28-7; 5-(1,2-Dithiolan-3-yl)pentanoic acid; DL-alpha-Lipoic acid; 1,2-dithiolane-3-pentanoic acid; 62-46-4; Lipothion; Thioctacid; dl-Lipoic acid; 6-Thioctic acid; DL-6-Thioctic acid; Liposan; Tioctacid; Rac-lipoate; 1,2-Dithiolane-3-valeric acid; Thioctic acid dl-form; alpha-liponic acid; Tioctidasi; (RS)-Lipoic acid; 6,8-Dithiooctanoic acid; (+-)-Lipoic acid; alpha-Liponsaeure; 5-(1,2-Dithiolan-3-yl)valeric acid; Thioktsaeure; espa-lipon; Acetate-replacing factor; (+/-)-1,2-Dithiolane-3-pentanoic acid; MFCD00005474; 5-(Dithiolan-3-yl)valeric acid; .alpha.-Lipoic acid; DL-1,2-Dithiolane 3-valeric acid; DL-1,2-Dithiolane-3-valeric acid; Thioctic acid [JAN]; Thioctansaeure; Thiooctic acid; a-lipoic acid; DL-.alpha.-Lipoic acid; lipoate; NSC 90788; C8H14O2S2; NSC 628502; (+-)-1,2-Dithiolane-3-pentanoic acid; .alpha.-Liponic acid; DTXSID7025508; DL-1,2-Dithiolan-3-valeriansaeure; (.+-.)-Lipoic acid; (RS)-.alpha.-Lipoic acid; CHEMBL33864; (.+-.)-.alpha.-Lipoic acid; 1,2-DITHIOLANE-3-VALERIC ACID, (+-)-; NSC90788; rac a-Lipoic Acid; dl-1,2-Dithiolane-3-pentanoic acid; Thioctic acid (JAN); NCGC00016032-06; 5-[3-(1,2-dithiolanyl)]pentanoic acid; Protogen A; 6,8-Thiotic acid; DTXCID705508; Thioktsaeure [German]; Alipure; Thiotacid; Pyruvate oxidation factor; 6-Thiotic acid; alpha-Liponsaeure [German]; alpha-lipon 300; SMR000058198; CAS-1077-28-7; (+-)-Thioctic acid; 5-(3-(1,2-DITHIOLANYL))PENTANOIC ACID; Tioctidasi acetate replacing factor; (R)-(+)-alpha-Lipoic acid;R-(+)-Thioctic acid; SR-01000737460; DL-6,8-DITHIOOCTANOIC ACID; Lip(S2); (RS)-alpha-Lipoic acid; EINECS 200-534-6; EINECS 214-071-2; (+-)-alpha-lipoic acid; BRN 0081853; BRN 0122410; duralipon; Thioctsaeure; liponic acid; UNII-73Y7P0K73Y; Alpha-Lipogamma; Alphalipoic-acid; Thioctacide T; DL-1,2-Dithiolan-3-valeriansaeure [German]; Thioctic acid [INN:BAN:JAN]; HSDB 7818; D,L-Lipoic acid; Alpha-Lipon Stada; Thiotomin (TN); DL-a-Lipoic acid; Thioctic acid CRS; I<<-Lipoic acid; |_-Lipoic Acid; D,L-Thioctic acid; lipoic acid (LA); Liponsaure-ratiopharm; rac ?-Lipoic Acid; (RS)-thioctic acid; (R)-a-Lipoic acid; LIPOIC-ACID; ()-alpha-Lipoic acid; Spectrum_001618; Thioctic acid, dl-form; (+)-?-Lipoic acid; D,L-alpha-Lipoic Acid; (+/-)-thioctic acid; 1,2-Dithiolane-3-pentanoic acid, (+-)-; Spectrum2_001605; Spectrum3_001188; Spectrum4_000217; Spectrum5_001298; (+/-)-a-Lipoic acid; cid_864; (.+-.)-Thioctic acid; Lipoic acid, alpha [NF]; bmse000542; Epitope ID:150922; (.+/-.)-Lipoic acid; THIOCTIC ACID [MI]; R)-(+)-alpha-Lipoic acid; SCHEMBL51065; BSPBio_002835; KBioGR_000853; KBioSS_002098; THIOCTIC ACID [HSDB]; 5-19-07-00237 (Beilstein Handbook Reference); MLS000069736; MLS001332379; MLS001332380; MLS002153365; DivK1c_000912; SPECTRUM1503941; SPBio_001609; THIOCTIC ACID [MART.]; orb1227028; orb1304833; orb1310842; THIOCTIC ACID [WHO-DD]; SCHEMBL27003112; BDBM10515; HMS502N14; HY-N0492R; KBio1_000912; KBio2_002098; KBio2_004666; KBio2_007234; KBio3_002335; A-LIPOICUM ACIDUM [HPUS]; MSK1780; ALPHA LIPOIC ACID [VANDF]; ALPHA-LIPOIC ACID [VANDF]; NINDS_000912; thioctic acid (alpha-lipoic acid); Thioctic Acid; Alpha Lipoic Acid; GLXC-15365; HMS1922M22; HMS3649H08; HMS3885I16; HMS5082F13; HMS5082J13; HMS6018C15; Pharmakon1600-01503941; THIOCTIC ACID, (+/-)-; ALBB-030318; ALPHA LIPOIC ACID [USP-RS]; HY-N0492; MSK10003; THIOCTIC ACID DL-FORM [MI]; Tox21_110285; Tox21_201808; Tox21_303092; AC7875; BBL013878; CCG-39063; EBC-03318; NSC628502; NSC758651; s3996; s3998; SBB003484; STK801969; THIOCTIC ACID [EP MONOGRAPH]; ()-1,2-Dithiolane-3-pentanoic acid; AKOS000121582; AKOS016339634; Tox21_110285_1; AB09328; CS-4370; FL00461; KS-1322; NSC-758651; SB49517; IDI1_000912; Thioctic acid containing impurity B CRS; (+/-)-1,2-Dithiolane-3-valeric acid; ALPHA LIPOIC ACID [USP IMPURITY]; NCGC00016032-02; NCGC00016032-03; NCGC00016032-04; NCGC00016032-05; NCGC00016032-07; NCGC00016032-08; NCGC00016032-09; NCGC00016032-11; NCGC00016032-14; NCGC00090872-01; NCGC00090872-02; NCGC00090872-03; NCGC00090872-04; NCGC00090872-05; NCGC00256970-01; NCGC00259357-01; Thioctic acid for system suitability CRS; (+/-)-alpha-Lipoic acid, >=98.0%; .ALPHA.-LIPOIC ACID, (+/-)-; AC-22673; BP-31070; NCI60_042014; R)-(+)-|A-Lipoic acid OOEthyAoEthAEa; R-(+)-1,2-Dithiolane-3-pentanoic acid; ST073359; SY010902; 1,2-dithiolane-3-pentanoic acid, racemic; SBI-0051871.P002; 5-(1,2-Dithiolan-3-yl)pentanoic acid #; DB-050522; 1,2-Dithiolane-3-pentanoic acid, (+/-)-; 1,2-Dithiolane-3-valeric acid, (.+-.)-; CS-0694773; L0058; L3561; NS00001602; 1,2-Dithiolane-3-pentanoic acid, (.+-.)-; 1,2-Dithiolane-3-valeric acid, (.+/-.)-; EN300-17612; 1,2-Dithiolane-3-pentanoic acid, (.+/-.)-; C00725; D00086; AB00052393_09; AL-398/25017043; F079457; Q312229; 1,2-Dithiolane-3-pentanoic acid, (+-)- (9CI); J-520421; SR-01000737460-2; SR-01000737460-6; 5-((3RS)-1,2-DITHIOLAN-3-YL)PENTANOIC ACID; BRD-A16347691-001-13-1; Z56969297; F2191-0208; .DELTA.-(3-(1,2-DITHIACYCLOPENTYL))PENTANOIC ACID; Thioctic acid, European Pharmacopoeia (EP) Reference Standard; (+/-)-alpha-Lipoic acid, BioReagent, cell culture tested, >=99%; (+/-)-alpha-Lipoic acid, synthetic, >=99% (titration), powder; 1,2-Dithiolane-3-pentanoic acid; 5-(1,2-Dithiolan-3-yl)valeric acid; Alpha Lipoic Acid, United States Pharmacopeia (USP) Reference Standard; Thioctic acid containing impurity B, European Pharmacopoeia (EP) Reference Standard; Thioctic acid for system suitability, European Pharmacopoeia (EP) Reference StandardSynonyms